BONE MARROW FAILURE
Clinical trials for BONE MARROW FAILURE explained in plain language.
Never miss a new study
Get alerted when new BONE MARROW FAILURE trials appear
Sign up with your email to follow new studies for BONE MARROW FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakthrough transplant aims to cut immune drugs and infections in bone marrow failure patients
Disease control Recruiting nowThis study tests a special stem cell transplant that removes certain immune cells to lower the need for strong anti-rejection drugs. It is for people with inherited bone marrow failure disorders like Fanconi anemia. The goal is to help the immune system recover faster and reduce …
Matched conditions: BONE MARROW FAILURE
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New transplant approach aims to fix immune system in rare diseases
Disease control Recruiting nowThis study tests a stem cell transplant using milder chemotherapy for people with certain immune deficiencies or bone marrow failure. The goal is to see if donor cells can take over the bone marrow and restore a working immune system. About 27 participants will be enrolled, and t…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
Cord blood transplants offer hope for kids without a donor match
Disease control Recruiting nowThis study tests whether a cord blood transplant can help children and young adults (up to age 21) with life-threatening blood cancers or genetic blood disorders who do not have a matched family donor. The main goal is to see how many patients survive one year after the transplan…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New cell addback aims to slash infection risk in child stem cell recipients
Disease control Recruiting nowThis study tests whether adding a specific type of immune cell (memory T cells) after a stem cell transplant can help prevent serious viral and fungal infections. About 100 children and young adults with blood cancers, immune disorders, or bone marrow failure will receive this ex…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 26, 2026 12:02 UTC